"/> Novus Biologicals™ Peptide bloquant d’anticorps EF… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps EFCAB4A

Réf. : BL-RE-045527Réf. fabricant : 18289685 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
283229
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76492. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 15 amino acids near the center of human EFCAB4A.

Points forts

Source

Synthetic

(Accession #: NP_775855) The EFCAB4A Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-045527
Réf. fabricant18289685
Gene ID (Entrez)283229
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76492. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneCalcium release-activated calcium channel regulator 2 B, CRAC channel regulator 2 B, CRACR2B, EF-hand calcium binding domain 4 A, EF-hand calcium-binding domain-containing protein 4 A, FLJ46033, MGC45840, MGC88858
Symbole de gène(s)CRACR2B
Type de produitEFCAB4A
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne15 amino acids near the center of human EFCAB4A
Une question, une configuration particulière ?
Contactez-nous pour un devis.